Drugs / ENZACAMENE
ENZACAMENE
also known as
4-methylbenzylidene camphor · Enzacamene d-l form · Enzacameno · Methylbenzylidene camphor
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00530387 | Jul 2008 → Jul 2011 | photoallergic dermatitis | NHS Tayside | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENZACAMENE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104261 ↗ |
| Known as | 4-methylbenzylidene camphor | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104261 ↗ |
| Known as | Enzacamene d-l form | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104261 ↗ |
| Known as | Enzacameno | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104261 ↗ |
| Known as | Methylbenzylidene camphor | “Methylbenzylidene camphor” NCT00530387 ↗ |
| Modality | Small molecule | — CHEMBL2104261 ↗ |